Miromatrix Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Net Income	-27.41	-29.96	-14.67	-10.31	-4.05
Depreciation & Amortization	1.16	1.11	0.17	0.17	0.34
Share-Based Compensation	1.23	1.15	0.62	0.64	0.92
Other Operating Activities	0.71	1.02	-0.93	1.46	-5.54
Operating Cash Flow	-24.31	-26.68	-14.81	-8.04	-8.32
Capital Expenditures	-0.24	-1.06	-3.38	-0.12	-0.1
Acquisitions	0	0	0	0	2.5
Change in Investments	16.26	-20.03	2	3	7.97
Investing Cash Flow	16.02	-21.09	-1.38	2.88	10.36
Share Issuance / Repurchase	9.01	0.79	45.5	0.06	0.06
Debt Issued / Paid	-0.07	-0.39	-0.04	6.29	0.25
Other Financing Activities	-0.07	-0.24	19.89	-	-
Financing Cash Flow	8.87	0.17	65.36	6.36	0.31
Net Cash Flow	0.58	-47.6	49.17	1.19	2.35
Free Cash Flow	-24.55	-27.75	-18.19	-8.16	-8.43
Free Cash Flow Margin	-2562.59%	-2909.97%	-55018.28%	-17539.04%	-3370.47%
Free Cash Flow Per Share	-0.90	-1.34	-1.58	-3.77	-4.12

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).